SCHEMBL1973299

SCHEMBL1973299

CC(C)=NNc1ccccn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.59
NPC1 O15118 9/20 0.59
GAA P10253 7/20 0.59
SMN1; SMN2 Q16637 6/20 0.59
MAPT P10636 6/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
HTT P42858 1/20 0.56
L3MBTL1 Q9Y468 3/20 0.50
PKM P14618 1/20 0.47
PAX8 Q06710 1/20 0.45
MAPK10 P53779 1/20 0.45
GFER P55789 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831618 0.85 RAB9A (0.56) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL6715793 0.82 PAX8 (0.67) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL15315184 0.82 RAB9A (0.60) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL28689206 0.82 RAB9A (0.54) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL20101085 0.82 PAX8 (0.67) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL6715790 0.82 PAX8 (0.67) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL20101098 0.82 MAPT (0.73) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL15267189 0.77 KDM4E (0.58) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL12727643 0.74 TOP2A (0.59) RAB9ANPC1GAASMN1; SMN2MAPT
SCHEMBL23550666 0.74 LMNA (0.55) RAB9ANPC1GAASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165350-A1 SURFACE LINKERS FOR ARRAY SYNTHESIS AFFYMETRIX, INC. (US) 2013-06-27 US disclosed
US-20110143967-A1 SURFACE MODIFICATIONS AND METHODS FOR THEIR SYNTHESIS AND USE AFFYMETRIX, INC. 2011-06-16 US disclosed
US-20110143966-A1 Surface Modifications and Methods for their Synthesis and Use AFFYMETRIX, INC. (US) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110143966-A1 Surface Modifications and Methods for their Synthesis and Use SDC4, SDC1, SDC2 RAB9A 4053/4885NPC1 4368/4885GAA 2346/4885
US-20110143967-A1 SURFACE MODIFICATIONS AND METHODS FOR THEIR SYNTHESIS AND USE SDC4, SDC1, SDC2 RAB9A 4053/4885NPC1 4368/4885GAA 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.